JPWO2019173291A5 - - Google Patents

Info

Publication number

JPWO2019173291A5

JPWO2019173291A5 JP2020546997A JP2020546997A JPWO2019173291A5 JP WO2019173291 A5 JPWO2019173291 A5 JP WO2019173291A5 JP 2020546997 A JP2020546997 A JP 2020546997A JP 2020546997 A JP2020546997 A JP 2020546997A JP WO2019173291 A5 JPWO2019173291 A5 JP WO2019173291A5

Authority

JP

Japan

Prior art keywords

seq

variable region

chain variable

polypeptide sequence

heavy chain

Prior art date

2022-03-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 claims description 195
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 195
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 195
• 239000000427 antigen Substances 0.000 claims description 37
• 102000036639 antigens Human genes 0.000 claims description 37
• 108091007433 antigens Proteins 0.000 claims description 37
• 239000012634 fragment Substances 0.000 claims description 37
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims description 23
• 102100022464 5'-nucleotidase Human genes 0.000 claims description 20
• 238000000034 method Methods 0.000 claims description 18
• 239000008194 pharmaceutical composition Substances 0.000 claims description 11
• 210000004027 cell Anatomy 0.000 claims description 9
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 6
• 102000039446 nucleic acids Human genes 0.000 claims description 6
• 108020004707 nucleic acids Proteins 0.000 claims description 6
• 150000007523 nucleic acids Chemical class 0.000 claims description 6
• 230000000694 effects Effects 0.000 claims description 5
• 206010028980 Neoplasm Diseases 0.000 claims description 4
• 201000011510 cancer Diseases 0.000 claims description 4
• 238000004519 manufacturing process Methods 0.000 claims description 4
• 210000004369 blood Anatomy 0.000 claims description 3
• 239000008280 blood Substances 0.000 claims description 3
• 238000006471 dimerization reaction Methods 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 3
• 102000045309 human NT5E Human genes 0.000 claims description 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 2
• 230000003213 activating effect Effects 0.000 claims description 2
• 238000012258 culturing Methods 0.000 claims description 2
• 230000002255 enzymatic effect Effects 0.000 claims description 2
• 230000001939 inductive effect Effects 0.000 claims description 2
• 230000002401 inhibitory effect Effects 0.000 claims description 2
• 238000002156 mixing Methods 0.000 claims description 2
• 230000005945 translocation Effects 0.000 claims 1
• 238000013508 migration Methods 0.000 description 2
• 230000005012 migration Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 108010028584 nucleotidase Proteins 0.000 description 1